Pandemic Provides Opportunity for Evaluation of Mental Health; MindCure and MindMed Lead With Ibogaine Mar 8, 2021
PharmaTher Expands to Neuromuscular Diseases with Exclusive License Agreement for Ketamine in the Treatment of Lou… Mar 2, 2021
Mydecine Fully Completes the First-Ever International Export of Psilocybin Mushrooms and Solidifies its Clinical and… Mar 1, 2021
PharmaDrug Files For FDA Orphan Drug Designation For DMT In Kidney Transplantation and Expands on Its Psychedelics… Feb 25, 2021
PharmaTher Announces Research Collaboration with Terasaki Institute for Novel Microneedle Delivery of Psychedelic… Feb 23, 2021
Mindset Pharma Agrees to Manufacture Large Quantity of Pharmaceutical Grade Psilocybin Using Patent-Pending Synthesis… Feb 22, 2021
